UNITED Therapeutics (UTHR) executive compensation, 2026 proxy

Martine Rothblatt, Chairperson and Chief Executive Officer, was paid $18M in 2025, down 22% from $23M the year before. The CEO-to-median-employee pay ratio was 76:1, on median employee pay of $237,406.

Filed
April 29, 2026
Annual meeting
June 26, 2026
Pay year
2025
Named executives
4
CEO total pay
$18M-22% vs prior year
CEO to median employee
76:1median $237,406
CEO pay in equity
67%$12.1M in awards
Prior say-on-pay support
95%of votes cast
CEO Total Compensation
$18.0M2025 total compensation
Say-on-Pay Support
95%2025 annual meeting support
CEO Base Salary
$1,545,0052025 base salary
CEO Non-Equity Incentive
$4,281,8752025 milestone cash bonus

How Rothblatt was paid

$18M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary9%Stock awards34%Option awards34%Non-equity incentive24%Pension and deferred comp0%All other compensation0%

Named executive officers

ExecutiveTotal
Martine RothblattChairperson and Chief Executive Officer$18,038,972
James EdgemondChief Financial Officer and Treasurer$8,348,367
Michael BenkowitzPresident and Chief Operating Officer$14,385,655
Paul MahonExecutive Vice President and General Counsel$5,531,313

What changed and why

  • $18MCEO total compensation decreased to $18,038,972 in 2025 from $23,009,609 in 2024.
  • 95%Shareholders overwhelmingly approved the previous say-on-pay proposal with over 95 percent support.
  • 100%Long-term incentive awards are 100 percent performance-based and delivered as stock options and RSUs.
  • Mr. Benkowitz received a base pay and bonus target increase following expanded responsibilities.
  • Mr. Edgemond received a pay increase reflecting broader real estate responsibilities.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.